Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
IRWD: Ironwood Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
IRWD
The Story
IRWD
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Operating margin
55.8%
ROIC
30.0%
Financially safe
Strong
Debt / equity
-2.75×
Interest coverage
6.0×
Current ratio
1.41×
Valuation
Unrated
P/E ratio
6.7×
Ironwood Pharmaceuticals, Inc.
IRWD
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Ironwood Pharmaceuticals, Inc.
IRWD
NASDAQ
·
USD
·
Closed
$4.23
+13.40%
$4.23
+$0.50 (13.40%)
52W Range
69th
pctl
Volume
1.45×
avg
Mkt Cap
696.31M
USD
P/E
6.7
TTM
Div Yield
–
ann
52W Range
69th
pctl
Volume
1.45×
avg
Market Cap
696.31M
USD
P/E Ratio
6.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings